| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.00094 | 1 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.00081 | 1 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.00074 | 1 |